---
audienceLevel: patient
cancerTypes:
- neuroblastoma
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- cancer-type
title: Neuroblastoma Research - NCI
url: https://www.cancer.gov/types/neuroblastoma/research
version: v1
---

# Neuroblastoma Research - NCI

# Neuroblastoma Research

- [Study Confirms Dinutuximab Extends Life for Children with High-Risk Neuroblastoma](/news-events/cancer-currents-blog/2022/study-confirms-dinutiximab-high-risk-neuroblastoma)

Posted: September 6, 2022

Researchers have confirmed that the immunotherapy drug dinutuximab (Unituxin) can help children with high-risk neuroblastoma live longer. The finding is based on a trial of nearly 1,200 children with the disease.
- [For Children with Neuroblastoma, Trial Results Highlight Continued Evolution of Treatment](/news-events/cancer-currents-blog/2019/high-risk-neuroblastoma-tandem-transplant)

Posted: September 23, 2019

For many children with high-risk neuroblastoma, receiving two separate stem cell transplants is more beneficial than receiving one, according to the results of an NCI-supported clinical trial conducted by the Childrenâ€™s Oncology Group.
- [New Drug for Pediatric Neuroblastoma Shows Promise in Preclinical Studies](/news-events/cancer-currents-blog/2015/fact-target-neuroblastoma)

Posted: December 17, 2015

An international research team has identified a possible new treatment target for pediatric neuroblastoma and is planning an early-stage clinical trial of a drug that inhibits this target.
